Loading
NASDAQHealthcareMedical - Devices
Latest quote
$4.59
−$0.09 · -1.92%
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Previous close
$4.59
−$0.09 · -1.92%
Regular session · ET · Market data may be delayed.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Day range
Current $4.59
52-week range
Current $4.59
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Sell
Trim exposure — unfavorable risk-reward
Valuation
45
Fair Value
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Day range
Current $4.59
52-week range
Current $4.59
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cost of goods sold | 12K USD | — | — | — | — |
| Gross profit | −12K USD | — | — | — | — |
| Research and development | 7.14M USD | 4.73M USD | 2.23M USD | 745K USD | 4.07K USD |
| Selling, general, and administrative | 9.89M USD | 6.86M USD | 5.25M USD | 1.25M USD | 13.59M USD |
| Operating expenses | 17.02M USD | 11.59M USD | 12.03M USD | 1.99M USD | 13.59M USD |
| Interest income | 319K USD | 354K USD | 127K USD | — | — |
| Interest expense | — | 176K USD | 79K USD | — | 218.09K USD |
| Depreciation and amortization | 12K USD | 183K USD | 81K USD | — | — |
| Operating income | −17.03M USD | −11.59M USD | −12.03M USD | −1.99M USD | −13.59M USD |
| Net income | −16.72M USD | −11.41M USD | −15.43M USD | −1.99M USD | −13.33M USD |
Company facts updated Sep 6, 2026.
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
